Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts

NCT03160079 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Acute Lymphoblastic Leukemia, Adult

Interventions

DRUG: blinatumomab
DRUG: pembrolizumab

Sponsor

University of California, San Diego

Collaborators

[object Object]
[object Object]